Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

A Study to Compare rhuFab V2 With Verteporfin Photodynamic in Treating Subfoveal Neovascular Macular Degeneration

ClinicalTrials.gov ID: NCT00061594

Public ClinicalTrials.gov record NCT00061594. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 2, 2026, 11:03 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Phase III, Multicenter, Randomized, Double Masked, Active Treatment-Controlled Study of the Efficacy and Safety of rhuFab V2 (Ranibizumab) Compared With Verteporfin (Visudyne) Photodynamic Therapy in Subjects With Predominantly Classic Subfoveal Neovascular Age-Related Macular Degeneration

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This is a phase III, multicenter, randomized, double-masked, active treatment-controlled study of intravitreally administered ranibizumab compared with verteporfin (Visudyne) photodynamic therapy (PDT) in treating subfoveal neovascular mascular degeneration.

Study identification

NCT ID
NCT00061594
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
Genentech, Inc.
Industry
Enrollment
426 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
50 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 30, 2003
Primary completion
Not listed
Completion
Aug 31, 2006
Last update posted
Mar 18, 2014

2003 – 2006

United States locations

U.S. sites
70
U.S. states
26
U.S. cities
63
Facility City State ZIP Site status
Retina Centers, P.C. Tucson Arizona 85704
University of Arizona Tucson Arizona 85711
Retina-Vitreous Associates Medical Group Beverly Hills California 90211
UC Irvine Irvine California 92697
Doheny Eye Institute Los Angeles California 90033
California Vitreoretinal Research Center Menlo Park California 94025
No. California Retina-Vitreous Associates Mountain View California 94040
UCSF School of Medicine San Francisco California 94143
Danbury Eye Physicians & Surgeons Danbury Connecticut 06810
New England Retina Associates Hamden Connecticut 06518
Florida Retina Institute Daytona Beach Florida 32114
Retina Vitreous Consultants Fort Lauderdale Florida 33334
Retina Consultants of Southwest Florida Fort Myers Florida 33901
Retina Health Center Fort Myers Florida 33901
Retina Associates of South Florida Margate Florida 33063
Bascom Palmer Eye Institute Miami Florida 33136
Central Florida Retina Orlando Florida 32806
Retina Care Specialists Palm Beach Gardens Florida 33410
Bascom Palmer Eye Institute Palm Beach Gardens Florida 33418
Ophthalmic Consultants Sarasota Florida 34239
Southern Vitreoretinal Associates PA Tallahassee Florida 32308
University of South Florida Tampa Florida 33612
Emory University Atlanta Georgia 30322
Medical College of Georgia Augusta Georgia 30912
Thomas A. Ciulla, MD, PC Indianapolis Indiana 46280
University of Kansas Medical Center Kansas City Kansas 66160
Retina Associates PC Annapolis Maryland 21401
New England Eye Center Boston Massachusetts 02111
Center for Eye Research Boston Massachusetts 02114
New England Retina Consultants West Springfield Massachusetts 01089
University of Michigan Ann Arbor Michigan 48105
Associated Retinal Consultants Grand Rapids Michigan 49546
Associated Retinal Consultants, P.C. Royal Oak Michigan 48073
Retina Consultants of Michigan Southfield Michigan 48034
Retina Associates of St. Louis Florissant Missouri 63031
St. Louis University Eye Institute St Louis Missouri 63104
Delaware Valley Retina Associates Lawrenceville New Jersey 08648
Lions Eye Institute Albany New York 12208
Ophthalmic Consultants of Long Island Rockville Centre New York 11570
Western Carolina Retinal Associates, PA Asheville North Carolina 28803
Southeast Clinical Research Charlotte North Carolina 28210
Duke Univ Medical Center/Duke Eye Center Durham North Carolina 22710
Retina Associates of Cleveland Beachwood Ohio 44122
Flavio Company Cincinnati Ohio 45242
Cleveland Clinic Foundation/Cole Eye Institute Cleveland Ohio 44195
Midwest Retina Columbus Ohio 43215
Retina Vitreous Associates Toledo Ohio 43608
Retinal Associates of Oklahoma Oklahoma City Oklahoma 73120
Retina & Vitreous Center of So. Oregon Ashland Oregon 97520
Pennsylvania Retina Specialists Camp Hill Pennsylvania 17011
Wills Eye Hospital Philadelphia Pennsylvania 19107
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Retina Consultants of Charleston Charleston South Carolina 29414
Palmetto Retina Center Columbia South Carolina 29204
BH Regional Eye Institute Rapid City South Dakota 57701
Southeastern Retina Associates, P.C. Knoxville Tennessee 37909
Retina Vitreous Associates Nashville Tennessee 37203
Austin Retina Associates Austin Texas 78705
Brian Berger, MD P.A. Austin Texas 78705
Retina Specialists DeSoto Texas 75115
UTMB Galveston Texas 77555
Vitreoretinal Consultants Houston Texas 77030
Valley Retina Institute, P.A. McAllen Texas 78503
Univ of Texas Health Science Center San Antonio Texas 78229
Medical Center Ophthalmology San Antonio Texas 78240
Rocky Mountain Retina Consultants Salt Lake City Utah 84107
John Moran Eye Center/Univ of Utah Salt Lake City Utah 84132
Retina Group of Washington Fairfax Virginia 22031
Vitreoretinal Associates Seattle Washington 98104
Medical College of Wisconsin Milwaukee Wisconsin 53226

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

Non-U.S. locations

This page focuses on the U.S. directory. The official record also lists 12 non-U.S. sites.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT00061594, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Mar 18, 2014 · Synced Sep 2, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT00061594 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →